Stockreport

Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]

Krystal Biotech, Inc.  (KRYS) 
Last krystal biotech, inc. earnings: 11/4 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.krystalbio.com/investors
PDF Litigation Expenses: $12.5 million accrued in Q3 2024. Research and Development Expenses: $13.5 million for the quarter. Selling, General, and Administrative Expens [Read more]